Search clinical trials for: Toll-like receptor 4
Total 702 results
-
National Cancer Institute (NCI)TerminatedRhabdomyosarcoma | Rhabdomyosarcoma, Alveolar | Rhabdomyosarcoma, EmbryonalUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI); Dana-Farber Cancer Institute; University of... and other collaboratorsRecruitingKidney Cancer | Renal Cell Carcinoma | Breast Cancer | Ovarian Cancer | Rectal Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Colon CancerUnited States
-
Marmara UniversityCompletedFamilial Mediterranean Fever | Central SensitisationTurkey
-
University of UtahNational Cancer Institute (NCI)SuspendedOral Cavity Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Oropharyngeal... and other conditionsUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Massachusetts Eye and Ear InfirmaryWithdrawnMigraine Disorders | Vestibular Diseases | Vestibular MigraineUnited States
-
Merck Sharp & Dohme LLCCompletedObesity and Obesity-related Medical Conditions
-
Toray Industries, IncRecruitingMelanoma | Renal Cell Carcinoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumor | Cholangiocarcinoma | Bladder Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Cancer | Palpable Subcutaneous Malignant LesionsUnited States, France
-
Milton S. Hershey Medical CenterNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)CompletedOpioid-Related Disorders | Opiate Substitution TreatmentUnited States
-
Montefiore Medical CenterNot yet recruitingNausea | Vomiting | Nausea and VomitingUnited States
-
Merck Sharp & Dohme LLCTerminatedType 2 Diabetes Mellitus | Obesity Type 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCTerminated
-
University of MiamiNovo Nordisk A/SRecruitingCoronary Artery Disease | Type2 DiabetesUnited States
-
Yonsei UniversityCompletedDyslipidemiasKorea, Republic of
-
M.D. Anderson Cancer CenterRecruitingGlioblastoma | Anaplastic Oligoastrocytoma | Oligoastrocytoma | Oligodendroglioma | Anaplastic Oligodendroglioma | WHO Grade III Glioma | Diffuse Astrocytoma, IDH-Wildtype | WHO Grade II Glioma | Anaplastic Astrocytoma, IDH-WildtypeUnited States
-
National Cancer Institute (NCI)Active, not recruitingGlioblastoma | GliosarcomaUnited States, Puerto Rico
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
RenJi HospitalRecruitingObesity | Chronic Kidney DiseasesChina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Not yet recruitingDelirium, Postoperative
-
Hvidovre University HospitalRecruitingObesity | Multimorbidity | Obesity MorbidDenmark
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedObesity | Polycystic Ovarian Syndrome | Hepatic SteatosisUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Glioblastoma | Refractory GlioblastomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7United States, Canada
-
Merck Sharp & Dohme LLCTerminated
-
BiogenCompletedParkinson's DiseasePoland, Israel, Serbia
-
University of PaviaUnknownDiabetes Mellitus | Essential HypertensionItaly
-
Joshua Woolley, MD, PhDNot yet recruitingDepression | Parkinson DiseaseUnited States
-
Merck Sharp & Dohme LLCTerminated
-
Radboud University Medical CenterCompletedDiabetes Mellitus | Diabetes Mellitus, Non-Insulin-Dependent
-
Christopher D. VerricoRecruiting
-
University at BuffaloAstraZenecaTerminatedKidney Diseases | Type2 DiabetesUnited States
-
Washington University School of MedicineNovo Nordisk A/SNot yet recruitingEndometrial HyperplasiaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); BHR Pharma, LLCRecruitingEstrogen Receptor Positive | Ductal Breast Carcinoma In SituUnited States
-
Indiana UniversityCompleted
-
General Hospital of Ningxia Medical UniversityCompleted
-
SanofiAntaros MedicalCompleted
-
BiogenCompletedParkinson's DiseaseUnited Kingdom, Israel, India
-
Wales Cancer Trials UnitUnknownFatigue | Lung Cancer | Chemotherapeutic Agent Toxicity | Musculoskeletal ComplicationsUnited Kingdom
-
University of California, San FranciscoActive, not recruiting
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Johns Hopkins UniversityRecruiting
-
Aarhus University HospitalRigshospitalet, Denmark; Herlev HospitalRecruitingKidney Cancer | Renal Cell Carcinoma Metastatic | Drug Toxicity | Drug Side Effect | Drug MechanismDenmark
-
Novo Nordisk A/SActive, not recruitingNon-alcoholic SteatohepatitisSpain, Denmark, Taiwan, Korea, Republic of, Australia, Canada, India, Singapore, United States, Turkey, Poland, Italy, Belgium, Puerto Rico, United Kingdom, Malaysia, Germany, Portugal, Bulgaria, Czechia, France, Greece, Japan, Russian...
-
Novo Nordisk A/SCompletedType 2 Diabetes | Healthy Volunteers | High Blood Cholesterol LevelsGermany, Canada
-
Seattle Children's HospitalUniversity of WashingtonActive, not recruiting
-
Yale UniversityTerminatedBipolar Disorder | Healthy Controls | Delta-9-TetrahydroncannabinolUnited States
-
BiogenCompletedHealthyUnited Kingdom